Transparency Note | PureCraft uses nano-optimized formulation technology in its CBD products. This guide provides an honest assessment of what nano-CBD is, what the science supports, and where marketing claims exceed the evidence. Bioavailability estimates are ranges from published research with significant individual variation.

CBD is a fat-soluble (lipophilic) molecule — it dissolves readily in oils and fats but poorly in water. The human gastrointestinal tract is primarily an aqueous environment, and fat-soluble molecules face significant absorption barriers: they must form micelles with bile salts to be transported across the intestinal epithelium, they are subject to extensive first-pass liver metabolism, and they have limited ability to disperse in the aqueous contents of the gut. The result: oral CBD bioavailability of 6–20% for standard formulations — meaning 80–94% of a swallowed CBD dose is metabolized or excreted without reaching systemic circulation.
This bioavailability limitation has two practical consequences: (1) the effective per-dose CBD that reaches your system is lower than the label milligrams suggest; and (2) fat intake dramatically affects absorption — Millar et al. (2019) showed4–5x higher CBD plasma levels with a high-fat meal vs fasted state. Nano-emulsification is an approach to address the aqueous-dispersion problem that limits CBD absorption in a fasted or low-fat context.
Nano-emulsification is a formulation technology that breaks CBD oil intoextremely small droplets — typically 50–200 nanometers in diameter, compared to the micrometer-scale droplets in conventional oil emulsions. These nanoscale droplets are created through high-shear processing (sonication, microfluidization) combined with emulsifiers (lecithin, polysorbates, or other food-grade surfactants) that stabilize the tiny droplets and prevent them from coalescing back into larger oil phases.
The consequence of nanoscale droplet size:dramatically increased surface area andimproved water dispersibility. A nano-emulsified CBD product can mix with water-based liquids without separating (the 'water-soluble CBD' claim), and the small droplet size potentially improves intestinal absorption by several mechanisms: enhanced interaction with bile salt micelles, faster lymphatic transport via chylomicron formation, and potentially improved passive transcellular absorption across intestinal epithelial cells.
'Water-soluble CBD' is a marketing term — CBD itself is not water-soluble and remains a lipophilic molecule regardless of formulation. Whatnano-emulsified CBDprovides is water-dispersible CBD: the nanoscale droplets remain suspended in water-based solutions rather than separating (as conventional CBD oil does when mixed with water). This water-dispersibility is functionally useful for: mixing CBD into beverages, producing clear CBD water products, and improving the aqueous-gut-environment compatibility that limits conventional CBD oil absorption.
The bioavailability evidence for nano-emulsified CBD ispositive but limited. The most important study: Zgair et al. (2016) demonstrated that lipid-based CBD formulations (which share the principle of improved fat-mediated absorption with nano-emulsions) produced significantly higher CBD plasma levels than conventional formulations. Nano-specific CBD bioavailability studies are fewer and have smaller sample sizes than the broader CBD pharmacokinetic literature.
What the available data suggests: nano-emulsified CBD producesfaster onset (10–30 min vs 15–45 min for sublingual oil) andhigher peak plasma concentrationsat equivalent doses in some studies — consistent with the improved dispersibility reducing the absorption barrier. Estimated nano-CBD bioavailability ranges from 20–50%, compared to 6–20% for standard oral CBD. However, these are estimates from limited trials with significant variation — the '10x bioavailability' claims sometimes seen in CBD marketing are not supported by peer-reviewed human pharmacokinetic data.
The nano-CBD marketing landscape includes significant overstatement. Claims to evaluate critically:
Honest assessment:nano-emulsification is agenuine bioavailability improvement technology with a reasonable scientific basis. The improvement is real but more modest than aggressive marketing suggests — likely 1.5–3x improvement over standard CBD oil, not 10x. The primary practical benefits are faster onset and better water-dispersibility.

Nano-CBD's bioavailability improvement is most significant in situations where standard CBD bioavailability is most limited:
For most CBD wellness applications — daily HPA recalibration, consistent anxiety management, chronic anti-inflammatory support — the bioavailability difference between nano and standard CBD oil matters less thanconsistent daily use. The cumulative HPA and 5-HT1A effects that underlie CBD's primary wellness benefits are built through weeks of consistent dosing — whether each dose delivers 20mg bioavailable CBD or 25mg bioavailable CBD is less important than never missing a day. For users who consistently take their CBD Oil with breakfast (providing the fat-meal bioavailability boost), the nano advantage narrows further.
Standard MCT oil sublingual CBD — with the 60–90 second hold technique and fat-containing breakfast — can achieve comparable effective plasma levels to many nano-formulations without the premium price. Nano-formulation matters most when dosing conditions are inconsistent (variable meal fat content, fasted dosing, acute applications). PureCraft'sCBD Oil uses MCT oil carrier — one of the most bioavailability-friendly non-nano approaches available — as the formulation foundation.
|
Format |
Particle Size |
Estimated Bioavailability |
Onset |
Best For |
|
Standard CBD oil (MCT carrier, sublingual) |
N/A — molecular CBD in oil |
15–35% (sublingual + swallowed) |
15–45 min |
Dose flexibility, full entourage, cost efficiency |
|
Nano-emulsified CBD oil (water-soluble) |
50–200 nm droplets |
20–50% (higher absorption rate, faster onset) |
10–30 min |
Higher bioavailability per mg, faster onset, compatible with water-based drinks |
|
CBD softgel (lipid carrier — MCT, lecithin) |
N/A — lipid solution |
15–25% (lymphatic absorption) |
45–90 min |
Consistent dosing, taste-free, built-in lipid carrier |
|
Plain CBD capsule (powder) |
N/A — bulk powder |
6–15% (poor absorption) |
45–90 min |
Not recommended — lowest bioavailability option |
|
CBD gummies (swallowed) |
N/A — oral solid |
10–20% (with food) |
30–60 min |
Palatability, convenience, sleep-specific formulations (CBN+melatonin) |
|
CBD isolate powder (oral) |
N/A — crystalline |
6–15% (similar to capsule) |
45–90 min |
Precise CBD-only dosing, zero THC, tasteless in formulation |
The table's key insight: nano-emulsified CBD provides the highest estimated oral bioavailability (20–50%) and fastest onset (10–30 min), but standard sublingual oil with MCT carrier is close behind (15–35%) with less processing and better terpene preservation. The plain capsule row (6–15%) is the worst bioavailability option and should be avoided when alternatives are available.Fat-meal timing improves all oral formats — the bioavailability ranges in the table assume reasonable food intake conditions.
Not all nano-CBD products are equal — the term 'nano' is used loosely in the CBD industry. When evaluating a nano-CBD product:

Nano CBD is cannabidiol that has been processed into nanoscale droplets (50–200 nanometers) using emulsification technology. The small droplet size makes CBD more water-dispersible (it can mix into water-based products without separating) and potentially improves oral bioavailability by enhancing interaction with the intestinal absorption machinery. 'Nano CBD' and 'water-soluble CBD' are typically the same type of product — nano-emulsified CBD that can be mixed into aqueous liquids.
Potentially more bioavailable at equivalent labeled doses — meaning more of the mg you take reaches your bloodstream. The improvement is genuine but more modest than marketing often implies: likely 1.5–3x improvement in bioavailable fraction, not 10x. In practice, this means alower mg dose of nano-CBD may deliver equivalent plasma levels to a higher mg dose of standard CBD oil. If your effective standard Oil dose is 20mg, a well-formulated nano-CBD product might achieve similar plasma levels at 10–15mg. The practical benefit depends on whether this bioavailability improvement matters for your specific application — for acute dosing and fasted-state use, it matters more; for consistent daily wellness dosing with food, less so.
'Better' depends on the application. Water-soluble (nano-emulsified) CBD is:better for mixing into beverages (oil separates in water; nano disperses uniformly);better for fasted-state dosing (less dependent on dietary fat for absorption);better for faster onset applications. Standard CBD oil with MCT carrier is: better for full terpene entourage preservation; more cost-effective per mg CBD; simpler formulation without emulsifiers; and with fat-meal timing achieves comparable effective plasma levels. Neither is universally superior — the choice depends on how and when you take your CBD.
PureCraft usesnano-optimized MCT oil carrierformulation that improves CBD bioavailability through MCT's fat-mediated lymphatic absorption pathway. This is not full nano-emulsification (the CBD is not in 50–200nm droplets for water-dispersibility) but uses high-quality MCT carrier to maximize absorption through the lipid pathway. The result: a formulation that provides significantly better bioavailability than plain CBD oil or powder capsules, through a more stable and terpene-preserving approach than some nano-emulsification methods.CBD Oil taken with breakfast provides the fat-meal enhancement that most reliably produces high effective bioavailability.
Four practical bioavailability maximizers for standard CBD oil:
The Bottom Line: Nano Is Real But Not Magic
Nano-emulsification is a genuine bioavailability improvement technology with scientific support — it makes CBD more water-dispersible and likely increases absorbed fraction at equivalent doses, particularly under fasted or low-fat conditions. The improvement is real, the mechanism is sound, and the faster onset is a practical advantage for certain applications.
The marketing often exceeds the science, however — '10x bioavailability' is not what the evidence shows; 1.5–3x is more realistic. And for daily wellness applications where consistency matters more than peak plasma level optimization, a high-quality standard sublingual oil taken with a fat-containing meal achieves effective, consistent plasma levels without the nano premium.
PureCraft CBD Oil — MCT oil carrier, nano-optimized formulation. 15–20mg AM with fat-containing breakfast for optimal bioavailability.CBD+CBN Sleep Gummies nightly. Zero THC,batch-tested COA.browse all PureCraft CBD products.
Transparency Note| PureCraft uses MCT oil carrier nano-optimized formulation. Bioavailability claims are based on published research ranges — individual variation is significant. 'Nano CBD' claims in the broader industry vary widely in scientific support. PureCraft CBD products are not intended to diagnose, treat, cure, or prevent any disease.
•CBD Oil vs Capsules: Bioavailability and Format Comparison
•CBD Oil vs Gummies: Which Is Better for You?
•CBD Third-Party Testing and COA Guide 2026
•How to Find the Right CBD Dose 2027
•CBD for Beginners: Everything You Need to Know 2027
•Huestis (2007): Human cannabinoid pharmacokinetics — Chemistry & Biodiversity → PubMed 17712814
Medical Disclaimer | Autophagy research in the context of cancer requires oncologist guidance - CBD's autophagy effects in cancer cells are contex...
Read More
Medical Disclaimer | Vagal nerve stimulation devices (implanted VNS, transcutaneous auricular VNS) are medical devices requiring physician prescri...
Read More
Editorial Note | Epigenetics and biological aging is an advanced, rapidly evolving field. This guide presents the most current mechanistic evidenc...
Read More